Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Targeting of Anti-hk2 Antibody in mCRPC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04116164
Recruitment Status : Recruiting
First Posted : October 4, 2019
Last Update Posted : April 9, 2021
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Tomopath Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2021
Estimated Study Completion Date : December 31, 2021